Previous 10 | Next 10 |
Construction on Fishers, Indiana plant to commence this month and is expected to be completed in 2023 State-of-the-art manufacturing operations to enable Stevanato Group to better serve North America pharmaceutical customers Stevanato Group (NYSE:STVN), a glo...
Shares of Stevanato Group S.p.A. (NYSE:STVN) traded today at $28.66, eclipsing its 52-week high. So far today approximately 198,000 shares have been exchanged, as compared to an average 30-day volume of 961,000 shares. Stevanato Group S.p.A. (NYSE:STVN) defies analysts with a current pri...
Shares of Stevanato Group S.p.A. (NYSE:STVN) traded at a new 52-week high today of $26.92. This new high was reached on below average trading volume as 116,000 shares traded hands, while the average 30-day volume is approximately 955,000 shares. Stevanato Group S.p.A. (NYSE:STVN) defies ...
Shares of Stevanato Group S.p.A. (NYSE:STVN) traded today at $25.94, eclipsing its 52-week high. Approximately 267,000 shares have changed hands today, as compared to an average 30-day volume of 1.3 million shares. Based on a current price of $25.65, Stevanato Group S.p.A. is currently 3...
Despite snapping a four-day rally on Wednesday, healthcare stocks in the S&P 500 gained for two consecutive sessions to end the week ~1.8% higher, outperforming the ~0.6% loss in the broader index. Among healthcare stocks with more than $300M market cap and over 100K averag...
The following slide deck was published by Stevanato Group S.p.A. in conjunction with their 2021 Q2 earnings call. For further details see: Stevanato Group S.p.A. 2021 Q2 - Results - Earnings Call Presentation
Stevanato Group S.p.A. (STVN) Q2 2021 Results Conference Call August 19, 2021 08:30 AM ET Company Participants Lisa Miles - Head, IR Franco Stevanato - Executive Chairman Franco Moro - CEO and COO Marco Dal Lago - CFO Mauro Stocchi - Chief Business Officer Paolo Patri - Chief Technology Offic...
- Establishes Full Year 2021 Guidance - Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for t...
Stevanato Group S.p.A. (the “Company”), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today announced that the underwriters of the Company’s recently completed...
Stevanato Group S.p.A. (NYSE: STVN) a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced that it will issue financial results for the second quarter of fiscal year 2021 ...
News, Short Squeeze, Breakout and More Instantly...
Stevanato Group S.p.A. Company Name:
STVN Stock Symbol:
NYSE Market:
Stevanato Group S.p.A. Website:
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, announced today that it will issue financial results for the second quarter of 2024 on Tuesday, August 6, 2...
2024-07-04 19:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-24 21:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...